Acute Toxicity of a Combined Preparation of the Standardized Extracts of Scutellaria baicalensis GEORGI and Salvia miltiorrhiza BUNGE

황금 및 단삼 표준화시료의 급성독성에 관한 연구

  • Chang, Bo-Yoon (Unstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University) ;
  • Malla, Bindu (Unstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University) ;
  • Sohn, Dong-Hwan (Unstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University) ;
  • Kim, Yoon-Chul (Unstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University) ;
  • Kim, Sung-Yeon (Unstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University)
  • 장보윤 (원광대학교 약학대학 약품연구소) ;
  • 빈두말라 (원광대학교 약학대학 약품연구소) ;
  • 손동환 (원광대학교 약학대학 약품연구소) ;
  • 김윤철 (원광대학교 약학대학 약품연구소) ;
  • 김성연 (원광대학교 약학대학 약품연구소)
  • Received : 2011.07.29
  • Accepted : 2011.09.23
  • Published : 2011.09.30

Abstract

Acute toxicity of a combined preparation of the standardized extracts Scutellaria baicalensis GEORGI and Salvia miltiorrhiza BUNGE in a ratio of 3:1 was examined in male and female ICR mice. Mice were treated with the test substance intragastrically at a dose of 0 mg/kg, 5 mg/kg, 50 mg/kg, 500 mg/kg or 2,000 mg/kg and observed for two weeks. No death or abnormal clinical sign was shown during the observation period. Also there were no difference in net body weight gain, organ weight, and gross pathological findings at the terminal sacrifice. The results suggested that acute oral toxicity of a combined preparation of the standardized extracts is very low at the conditions employed in this study.

Keywords

References

  1. 정보섭, 신민교 (1990) 도해향약(생약)대사전(식물편), 5001-5009, 도서출판 영림사, 서울.
  2. 정보섭, 신민교 (1990) 도해향약(생약)대사전(식물편), 860-862, 도서출판 영림사, 서울.
  3. Sohn, D.H., Kim, Y.C., Park, E. J., and Zhao, Y.-Z. (2006) A purified extract isolated from Scutellaria baicalensis GEORGI, a method for preparing them and the composition comprising the same having hepato-protecting activity and protecting or treating activity from liver fibrosis and liver cirrhosis. Korea Patent, 10-2006-0048798
  4. Sohn, D.H., Kim, Y.C. and Park E.J. (2007) A purified extract isolated from Salvia miltiorrhiza, amethod for preparing them and the compositioncomprising the same having hepato-protecting activityand protecting or treating activity from liver fibrosisand liver cirrhos. Korea Patent, 10-2007-0113561.
  5. 식품의약품안전청 (1999) 의약품등의 독성시험기준, 식품의약품안전청고시, 1999-61, 식품의약품안전청.
  6. Organization for Economic Cooperation and Development (OECD) (2001) OECD Guideline for the Testing of Chemicals revised draft guideline 420.
  7. Wakabayashi, I. (1999) Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol. Toxicol. 84: 288-291. https://doi.org/10.1111/j.1600-0773.1999.tb01496.x
  8. Ikemoto, S., Sugimura, K., Yoshida, N., Yasumoto, R., Wada, S., Yamamoto, K. and Kishimoto, T. (2000) Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55: 951-955. https://doi.org/10.1016/S0090-4295(00)00467-2
  9. Hara, H., Sukamoto, T., Ohtaka, H., Abe, K., Tatumi, Y., Saito, Y., Suzuki, A. and Tsukamoto, G. (1992) Effects of baicalein and alpha-tocopherol on lipid peroxidation, free radical scavenging activity and 12-O-tetradecanoylphorbol acetate-induced ear edema. Eur. J. Pharmacol. 221: 193-198. https://doi.org/10.1016/0014-2999(92)90700-E
  10. Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y., Lu, H. T., Fan, K. W., Cheng, V. C., Tsui, W. H., Hung, I. F., Lee, T. S., Guan, Y., Peiris, J. S. and Yuen, K. Y. (2004) In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 31: 69-75.
  11. Chen, Y., Yang, L. and Lee, T. J. (2000) Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem. Pharmacol. 59: 1445-1457. https://doi.org/10.1016/S0006-2952(00)00255-0
  12. 노정구, 한상섭, 김용화, 김영구, 김성훈 (1986) 화학물질의 독성 평가 및 방법 개발보고서 86-10-0227-00-00, 한국화학연구원.
  13. 노정구, 한상섭, 김용화, 김성훈, 이현걸 (1987) 화학물질의 독성 평가 및 방법 개발 보고서 87-10-0319-00-00, 한국화학연구원.
  14. 김수현, 이혜영, 김선희, 박석희, 정미숙, 문설희, 이미영, 심용희, 서민수, 문제민, 강대혁, 서형석, 나재범 (2005) 생약(한약) 등의 90일 반복투여독성실험(황금). 독성물질국가관리사업연구보고서 4: 256-280, 식품의약품안전평가원.
  15. 이종권, 신지순, 이근영, 김형수, 김진호, 엄주호, 조수미, 조연옥, 길정현, 김정래, 전영진, 박귀례 (2004) 생약제제의 in vitro 면역독성연구보고서, 04-N-10, 식품의약품안전평가원.
  16. Kim, J. Y., Kim, K. M., Nan, J. X., Zhao, Y. Z., Park, P. H., Lee, S. J. and Sohn, D. H. (2003) Introduction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol. Toxicol. 92: 195-200. https://doi.org/10.1034/j.1600-0773.2003.920410.x
  17. Liu, Y., Wang, X. and Liu, Y. (2003) Protective effect of tan shinone IIA on injured primary cultured rat hepatocytes induced by CCL4. Zhong Yao Cai 26: 415-417.
  18. Liu, Y., Chen, H. and Jiang, Y. (2002) Effect of tanshinone IIA on CCL4-induced liver fibrosis in rats. Zhong Yao Cai 25: 31-33.
  19. Yuan, S. L., Wei, Y, Q,, Wang, X, J., Xiao, F., Li, S. F. and Zhang, J. (2004) Growth inhibition and apoptosis induction of tanshinone IIA on human hepatocelluar carcinoma cells. World J. Gastroenterol. 10: 2024-2028. https://doi.org/10.3748/wjg.v10.i14.2024
  20. Ueng, Y. F., Kuo, Y. H., Peng, H. C., Chen, T. L., Jan, W. C., Peter, G. F. and Lin, Y. L. (2001) Diterpene quinone tanshinone IIA selectivity inhibits mouse and human cytochrome P4501A2. Xenobiotica 33: 603-613.
  21. Chang, B. Y., Oh, B. R., Sohn, D. H. and Kim, S.Y. (2008) Single oral toxicity study in the standardozed extract of salvia miltiorrhiza. Kor. J. Pharmacogn. 39: 352-356.
  22. Chan, T. Y. (2001) Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother. 35: 501-504. https://doi.org/10.1345/aph.19029